coronavirus covid-19 sars-cov-2 test assay analysis point-of-care swab id now abbott labs mesa biotech cepheid fda emergency use authorization
FDA Gives Abbott Emergency Use of Five-Minute Coronavirus Test
The machine can be run in doctor’s offices and other point-of-care settings to give rapid results.
FDA Gives Abbott Emergency Use of Five-Minute Coronavirus Test
FDA Gives Abbott Emergency Use of Five-Minute Coronavirus Test

The machine can be run in doctor’s offices and other point-of-care settings to give rapid results.

The machine can be run in doctor’s offices and other point-of-care settings to give rapid results.

federal funding, microbiology

coronavirus covid-19 sars-cov-2 genome sequencing africa nigeria
Africa Contributes SARS-CoV-2 Sequencing to COVID-19 Tracking
Munyaradzi Makoni | Mar 30, 2020
In recent years, laboratories on the continent have ramped up genomic sequencing capabilities, offering in-country analyses rather than outsourcing the job.
COVID-19 Vaccine Developers Gain Enhanced Access to Supercomputers
Lisa Winter | Mar 27, 2020
Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.
EPA Protections Relaxed During Coronavirus Pandemic
Amy Schleunes | Mar 27, 2020
Citing potential worker shortages and the effects of restricted travel and social distancing, the Environmental Protection Agency announced a “sweeping suspension” of environmental regulations that some say gives companies free rein to pollute.
Animal Facilities Make Tough Decisions as Pandemic Closes Labs
Abby Olena | Mar 27, 2020
Many researchers have stopped breeding mice, reduced the size of colonies, and established contingency plans in case animal care staff get sick.
Universities Issue Hiring Freezes in Response to COVID-19
Amy Schleunes | Mar 26, 2020
Graduate students and postdocs are left wondering about the implications for their academic careers.
FDA to Allow for Plasma Therapy for COVID-19 Patients
Lisa Winter | Mar 26, 2020
Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  
Relatively Stable SARS-CoV-2 Genome Is Good News for a Vaccine
Amy Schleunes | Mar 25, 2020
The small number of genetic differences between the original strain of the novel coronavirus from Wuhan and those currently circulating in the US population indicates that a vaccine may likely offer lasting immunity.
Image of the Day: Coronavirus in 3D
Amy Schleunes | Mar 25, 2020
At Bessy II, a synchrotron radiation facility in Berlin, scientists use X-rays to study the structure of SARS-CoV-2.
chloroquine hydroxychloroquine covid-19 coronavirus sars-cov-2 malaria antimalarial antiviral
Chloroquine for COVID-19: Cutting Through the Hype
Chris Baraniuk | Mar 20, 2020
President Donald Trump has touted the drug as a treatment but scientists still don’t know for sure that it is effective in patients. A number of clinical trials aim to find out.
Opinion: Grad Students Face Uncertainty During the Pandemic
Lila Westreich | Mar 19, 2020
With mounting feelings of isolation, research projects derailed, and financial futures cast into doubt, grad students are anxious in the midst of the COVID-19 outbreak.
US Primate Centers Work to Protect Animals from COVID-19
Ashley Yeager | Mar 19, 2020
Rhesus macaques can be infected with SARS-CoV-2, leading primate center scientists to try to prevent outbreaks in their colonies, especially as experiments on coronavirus start.
Image of the Day: How COVID-19 Spreads
Amy Schleunes, Catherine Offord | Mar 19, 2020
International data from the European Centre for Disease Prevention and Control indicates a similar pattern in reported coronavirus cases during the first 10 days after the case count passes 500.
University of Washington Pathology Professor Dies of COVID-19
Jef Akst | Mar 19, 2020
Stephen Schwartz, known for his work on the vascular system, is the first person associated with the university to succumb to infection with SARS-CoV-2.
Image of the Day: Coronavirus Samples
Amy Schleunes | Mar 18, 2020
The University of Washington department of laboratory medicine in Seattle processes a backlog of COVID-19 samples.
a photo of boxes in a laboratory freezer
Bay Area Researchers Close Labs Under New Restrictions
The Scientist Staff | Mar 17, 2020
Under an area-wide “shelter in place” order, scientists at some of the world’s leading universities scramble to continue working while confined to their homes.
civet cat sars coronavirus sars-cov-2 covid-19 pandemic intermediate host zoonoses zoonotic
Which Species Transmit COVID-19 to Humans? We’re Still Not Sure.
Claire Jarvis | Mar 16, 2020
Preliminary modeling studies provide a shortlist of potential coronavirus intermediate host species.
Chinese Officials Blame US Army for Coronavirus
Lisa Winter | Mar 13, 2020
There is no evidence backing the idea that SARS-CoV-2 originated from US servicemembers visiting Wuhan.
coronavirus covid-19 sars-cov-2 modeling predictions projections when it will peak pandemic
Modelers Struggle to Predict the Future of the COVID-19 Pandemic
David Adam | Mar 12, 2020
Disease experts have largely focused on how we got to where we are now with coronavirus infections. Improved data collection and sharing can enhance projections of what’s to come.
coronavirus covid-19 sars-cov-2 surfaces plastic steel airborne aerosolized
SARS-CoV-2 Can Live on Plastic and Steel for 2–3 Days
Kerry Grens | Mar 12, 2020
A preprint indicates that coronavirus transmission from surfaces is possible, but does not provide evidence that this has occurred in the COVID-19 pandemic.